New York State Common Retirement Fund Biomarin Pharmaceutical Inc Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 98,245 shares of BMRN stock, worth $6.51 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
98,245
Previous 299,579
67.21%
Holding current value
$6.51 Million
Previous $24.7 Million
72.0%
% of portfolio
0.01%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.51 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.28 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.25 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$921 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$696 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...